Cellosaurus 22Rv1-CabR1 (CVCL_A6PG)
Cell line name | 22Rv1-CabR1 |
---|---|
Accession | CVCL_A6PG |
Resource Identification Initiative | To cite this cell line use: 22Rv1-CabR1 (RRID:CVCL_A6PG) |
Comments | Population: Caucasian. Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745). Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel. Derived from site: In situ; Prostate; UBERON=UBERON_0002367. |
Sequence variations |
|
Disease | Prostate carcinoma (NCIt: C4863) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1045 (22Rv1) |
Sex of cell | Male |
Age at sampling | Adult |
Category | Cancer cell line |
Publications | PubMed=31799745; DOI=10.1002/pros.23935; PMCID=PMC6973163 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_A6PG |
Encyclopedic resources | Wikidata; Q107113178 |
Entry history | |
Entry creation | 20-May-2021 |
Last entry update | 19-Dec-2024 |
Version number | 7 |